387 related articles for article (PubMed ID: 26388462)
1. BEST1: the Best Target for Gene and Cell Therapies.
Yang T; Justus S; Li Y; Tsang SH
Mol Ther; 2015 Dec; 23(12):1805-9. PubMed ID: 26388462
[TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cell Modeling of Best Disease and Autosomal Recessive Bestrophinopathy.
Lee JH; Oh JO; Lee CS
Yonsei Med J; 2020 Sep; 61(9):816-825. PubMed ID: 32882766
[TBL] [Abstract][Full Text] [Related]
3.
Guziewicz KE; Cideciyan AV; Beltran WA; Komáromy AM; Dufour VL; Swider M; Iwabe S; Sumaroka A; Kendrick BT; Ruthel G; Chiodo VA; Héon E; Hauswirth WW; Jacobson SG; Aguirre GD
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2839-E2848. PubMed ID: 29507198
[TBL] [Abstract][Full Text] [Related]
4. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
[TBL] [Abstract][Full Text] [Related]
5. Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation.
Johnson AA; Bachman LA; Gilles BJ; Cross SD; Stelzig KE; Resch ZT; Marmorstein LY; Pulido JS; Marmorstein AD
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4619-30. PubMed ID: 26200502
[TBL] [Abstract][Full Text] [Related]
6. Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.
Johnson AA; Lee YS; Chadburn AJ; Tammaro P; Manson FD; Marmorstein LY; Marmorstein AD
Exp Eye Res; 2014 Apr; 121():74-85. PubMed ID: 24560797
[TBL] [Abstract][Full Text] [Related]
7. BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.
Moshfegh Y; Velez G; Li Y; Bassuk AG; Mahajan VB; Tsang SH
Hum Mol Genet; 2016 Jul; 25(13):2672-2680. PubMed ID: 27193166
[TBL] [Abstract][Full Text] [Related]
8. Bestrophinopathy: An RPE-photoreceptor interface disease.
Guziewicz KE; Sinha D; Gómez NM; Zorych K; Dutrow EV; Dhingra A; Mullins RF; Stone EM; Gamm DM; Boesze-Battaglia K; Aguirre GD
Prog Retin Eye Res; 2017 May; 58():70-88. PubMed ID: 28111324
[TBL] [Abstract][Full Text] [Related]
9. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy.
Sinha D; Steyer B; Shahi PK; Mueller KP; Valiauga R; Edwards KL; Bacig C; Steltzer SS; Srinivasan S; Abdeen A; Cory E; Periyasamy V; Siahpirani AF; Stone EM; Tucker BA; Roy S; Pattnaik BR; Saha K; Gamm DM
Am J Hum Genet; 2020 Aug; 107(2):278-292. PubMed ID: 32707085
[TBL] [Abstract][Full Text] [Related]
10. A Novel BEST1 Mutation in Autosomal Recessive Bestrophinopathy.
Lee CS; Jun I; Choi SI; Lee JH; Lee MG; Lee SC; Kim EK
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8141-50. PubMed ID: 26720466
[TBL] [Abstract][Full Text] [Related]
11. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
12. BESTROPHINOPATHY: A Spectrum of Ocular Abnormalities Caused by the c.614T>C Mutation in the BEST1 Gene.
Toto L; Boon CJ; Di Antonio L; Battaglia Parodi M; Mastropasqua R; Antonucci I; Stuppia L; Mastropasqua L
Retina; 2016 Aug; 36(8):1586-95. PubMed ID: 26716959
[TBL] [Abstract][Full Text] [Related]
13. Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy.
Marmorstein AD; Johnson AA; Bachman LA; Andrews-Pfannkoch C; Knudsen T; Gilles BJ; Hill M; Gandhi JK; Marmorstein LY; Pulido JS
Sci Rep; 2018 Mar; 8(1):4487. PubMed ID: 29540715
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of family with autosomal recessive bestrophinopathy associated with new BEST1 mutation.
Kubota D; Gocho K; Akeo K; Kikuchi S; Sugahara M; Matsumoto CS; Shinoda K; Mizota A; Yamaki K; Takahashi H; Kameya S
Doc Ophthalmol; 2016 Jun; 132(3):233-43. PubMed ID: 27071392
[TBL] [Abstract][Full Text] [Related]
15. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
Maeda A; Mandai M; Takahashi M
Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
[TBL] [Abstract][Full Text] [Related]
16. iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration.
Singh R; Shen W; Kuai D; Martin JM; Guo X; Smith MA; Perez ET; Phillips MJ; Simonett JM; Wallace KA; Verhoeven AD; Capowski EE; Zhang X; Yin Y; Halbach PJ; Fishman GA; Wright LS; Pattnaik BR; Gamm DM
Hum Mol Genet; 2013 Feb; 22(3):593-607. PubMed ID: 23139242
[TBL] [Abstract][Full Text] [Related]
17. Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium.
Liu J; Taylor RL; Baines RA; Swanton L; Freeman S; Corneo B; Patel A; Marmorstein A; Knudsen T; Black GC; Manson F
Invest Ophthalmol Vis Sci; 2020 May; 61(5):28. PubMed ID: 32421148
[TBL] [Abstract][Full Text] [Related]
18. Bestrophin1: A Gene that Causes Many Diseases.
Smith JJ; Nommiste B; Carr AF
Adv Exp Med Biol; 2019; 1185():419-423. PubMed ID: 31884648
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
Croze RH; Clegg DO
Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
[TBL] [Abstract][Full Text] [Related]
20. Biallelic Mutations in the BEST1 Gene: Additional Families with Autosomal Recessive Bestrophinopathy.
Wivestad Jansson R; Berland S; Bredrup C; Austeng D; Andréasson S; Wittström E
Ophthalmic Genet; 2016 Jun; 37(2):183-93. PubMed ID: 26333019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
